open access

Vol 93, No 6 (2022)
Research paper
Published online: 2022-03-02
Get Citation

Increased clitoral artery pulsatility index and decreased sexual desire level in women with polycystic ovary syndrome

Sefik Gokce1, Dilsad Herkiloglu1, Nuray Bakal2, Meryem Eken3, Ates Karateke4
·
Pubmed: 35315011
·
Ginekol Pol 2022;93(6):473-477.
Affiliations
  1. Department of Obstetrics and Gynaecology, Gaziosmanpasa Hospital, Yeni Yuzyil University, Istanbul, Turkey
  2. Department of Radiology, Zeynep Kamil Training and Research Hospital, Istanbul, Turkey
  3. Department of Obstetrics and Gynaecology, Hisar Intercontinental Hospital, İstanbul, Turkey
  4. Department of Obstetrics and Gynaecology, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkey

open access

Vol 93, No 6 (2022)
ORIGINAL PAPERS Gynecology
Published online: 2022-03-02

Abstract

Objectives: Polycystic ovary syndrome (PCOS) is claimed to effect the sexual desire, and recently, blood flow in the clitoral artery (CA) was measured by Doppler ultrasound (USG) examination and the level of sexual desire was objectively demonstrated by determining the pulsatility index (PI). In the present study, it was aimed to quantitatively determine the sexual desire levels in women with PCOS using Doppler USG and to compare the data with healthy women.
Material and methods: The study included 71 patients diagnosed with PCOS and 78 healthy women who applied to our tertiary hospital gynecology clinics and for control purposes. Pulsatility indices were determined by measuring blood flows in the clitoral artery, uterine artery, ovarian artery and labial artery using Doppler USG in all participants. The clitoral artery pulsatility index was found to be increased significantly in women with PCOS. Results: The mean age was 28.5 ± 3.7 in the polycystic ovary syndrome group and 30.0 ± 5.2 in the control group. The mean clitoral artery pulsatility index (1.4 ± 0.5 cm/sec) in the PCOS group was significantly higher than the control group (1.2 ± 0.4 cm/sec) (p = 0.033 cm/sec).The mean ovarian artery pulsatility index (0.8 ± 0.2 cm/sec) in the PCOS group was also significantly higher than the control group (0.7 ± 0.2 cm/sec) (p = 0.015 cm/sec). PCOS is showed to influence sexual desire with an objective measurement. Since trying to obtain objective data about the level of sexual desire, questionnaires were not applied to the participants and no questions were asked.
Conclusions: In our study, it was found that the clitoral artery pulsatility index, that is, the rate of resistance in the blood flow to the clitoral region, increased significantly in women with PCOS. This finding shows that the level of sexual desire in women with PCOS has decreased compared to healthy women.

Abstract

Objectives: Polycystic ovary syndrome (PCOS) is claimed to effect the sexual desire, and recently, blood flow in the clitoral artery (CA) was measured by Doppler ultrasound (USG) examination and the level of sexual desire was objectively demonstrated by determining the pulsatility index (PI). In the present study, it was aimed to quantitatively determine the sexual desire levels in women with PCOS using Doppler USG and to compare the data with healthy women.
Material and methods: The study included 71 patients diagnosed with PCOS and 78 healthy women who applied to our tertiary hospital gynecology clinics and for control purposes. Pulsatility indices were determined by measuring blood flows in the clitoral artery, uterine artery, ovarian artery and labial artery using Doppler USG in all participants. The clitoral artery pulsatility index was found to be increased significantly in women with PCOS. Results: The mean age was 28.5 ± 3.7 in the polycystic ovary syndrome group and 30.0 ± 5.2 in the control group. The mean clitoral artery pulsatility index (1.4 ± 0.5 cm/sec) in the PCOS group was significantly higher than the control group (1.2 ± 0.4 cm/sec) (p = 0.033 cm/sec).The mean ovarian artery pulsatility index (0.8 ± 0.2 cm/sec) in the PCOS group was also significantly higher than the control group (0.7 ± 0.2 cm/sec) (p = 0.015 cm/sec). PCOS is showed to influence sexual desire with an objective measurement. Since trying to obtain objective data about the level of sexual desire, questionnaires were not applied to the participants and no questions were asked.
Conclusions: In our study, it was found that the clitoral artery pulsatility index, that is, the rate of resistance in the blood flow to the clitoral region, increased significantly in women with PCOS. This finding shows that the level of sexual desire in women with PCOS has decreased compared to healthy women.

Get Citation

Keywords

polycystic ovary syndrome (PCOS); clitoral artery blood flow; pulsatility index; PI; clitoral volume

About this article
Title

Increased clitoral artery pulsatility index and decreased sexual desire level in women with polycystic ovary syndrome

Journal

Ginekologia Polska

Issue

Vol 93, No 6 (2022)

Article type

Research paper

Pages

473-477

Published online

2022-03-02

Page views

4381

Article views/downloads

755

DOI

10.5603/GP.a2021.0219

Pubmed

35315011

Bibliographic record

Ginekol Pol 2022;93(6):473-477.

Keywords

polycystic ovary syndrome (PCOS)
clitoral artery blood flow
pulsatility index
PI
clitoral volume

Authors

Sefik Gokce
Dilsad Herkiloglu
Nuray Bakal
Meryem Eken
Ates Karateke

References (25)
  1. Meier RK. Polycystic Ovary Syndrome. Nurs Clin North Am. 2018; 53(3): 407–420.
  2. Nandi A, Chen Z, Patel R, et al. Polycystic ovary syndrome. Endocrinol Metab Clin North Am. 2014; 43(1): 123–147.
  3. McCartney CR, Marshall JC. CLINICAL PRACTICE. Polycystic Ovary Syndrome. N Engl J Med. 2016; 375(1): 54–64.
  4. Rothenberg SS, Beverley R, Barnard E, et al. Polycystic ovary syndrome in adolescents. Best Pract Res Clin Obstet Gynaecol. 2018; 48: 103–114.
  5. Barthelmess EK, Naz RK. Polycystic ovary syndrome: current status and future perspective. Front Biosci (Elite Ed). 2014; 6(1): 104–119.
  6. Goodarzi M, Dumesic D, Chazenbalk G, et al. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011; 7(4): 219–231.
  7. Bellver J, Rodríguez-Tabernero L, Robles A, et al. Group of interest in Reproductive Endocrinology (GIER) of the Spanish Fertility Society (SEF). Polycystic ovary syndrome throughout a woman's life. J Assist Reprod Genet. 2018; 35(1): 25–39.
  8. Li Li, Feng Q, Ye M, et al. Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis. J Obstet Gynaecol. 2017; 37(8): 1036–1047.
  9. Rodriguez-Paris D, Remlinger-Molenda A, Kurzawa R, et al. The occurrence of psychiatric disorders in women with polycystic ovary syndrome. Psychiatria Polska. 2019; 53(4): 955–966.
  10. Stovall DW, Scriver JL, Clayton AH, et al. Sexual function in women with polycystic ovary syndrome. J Sex Med. 2012; 9(1): 224–230.
  11. Karatas OF, Baltaci G, Ilerisoy Z, et al. The evaluation of clitoral blood flow and sexual function in elite female athletes. J Sex Med. 2010; 7(3): 1185–1189.
  12. Khalifé S, Binik YM, Cohen DR, et al. Evaluation of clitoral blood flow by color Doppler ultrasonography. J Sex Marital Ther. 2000; 26(2): 187–189.
  13. Oiwa Y, Watanabe T, Sadahira T, et al. Clitoral Blood Flow Changes after Surgery with Tension-Free Vaginal Mesh for Pelvic Organ Prolapse. Acta Med Okayama. 2019; 73(1): 21–27.
  14. Rosato E, Gigante A, Barbano B, et al. Clitoral blood flow in systemic sclerosis women: correlation with disease clinical variables and female sexual dysfunction. Rheumatology (Oxford). 2013; 52(12): 2238–2242.
  15. Battaglia C, Nappi RE, Mancini F, et al. PCOS, sexuality, and clitoral vascularisation: a pilot study. J Sex Med. 2008; 5(12): 2886–2894.
  16. Battaglia C, Nappi RE, Mancini F, et al. PCOS and urethrovaginal space: 3-D volumetric and vascular analysis. J Sex Med. 2010; 7(8): 2755–2764.
  17. Mercier J, Tang An, Morin M, et al. Test-retest reliability of clitoral blood flow measurements using color Doppler ultrasonography at rest and after a pelvic floor contraction task in healthy adult women. Neurourol Urodyn. 2018; 37(7): 2249–2256.
  18. Ozdemir O, Sari ME, Kalkan D, et al. Comprasion of ovarian stromal blood flow measured by color Doppler ultrasonography in polycystic ovary syndrome patients and healthy women with ultrasonographic evidence of polycystic. Gynecol Endocrinol. 2015; 31(4): 322–326.
  19. Eftekhar T, Sohrabvand F, Zabandan N, et al. Sexual dysfunction in patients with polycystic ovary syndrome and its affected domains. Iran J Reprod Med. 2014; 12(8): 539–546.
  20. Hashemi S, Ramezani Tehrani F, Farahmand M, et al. Association of PCOS and its clinical signs with sexual function among Iranian women affected by PCOS. J Sex Med. 2014; 11(10): 2508–2514.
  21. Yildiz A, Dogan O. Sexual dysfunction in women with polycystic ovary syndrome. Kocaeli Medical J. 2017; 6: 17–23.
  22. Morotti E, Persico N, Battaglia B, et al. Body imaging and sexual behavior in lean women with polycystic ovary syndrome. J Sex Med. 2013; 10(11): 2752–2760.
  23. Özay AC, Emekçi Özay Ö, Okyay RE, et al. The effect of myoinositol on ovarian blood flows in women with polycystic ovary syndrome. Gynecol Endocrinol. 2019; 35(3): 237–241.
  24. Mala YM, Ghosh SB, Tripathi R. Three-dimensional power Doppler imaging in the diagnosis of polycystic ovary syndrome. Int J Gynaecol Obstet. 2009; 105(1): 36–38.
  25. Adali E, Kolusari A, Adali F, et al. Doppler analysis of uterine perfusion and ovarian stromal blood flow in polycystic ovary syndrome. Int J Gynaecol Obstet. 2009; 105(2): 154–157.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl